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Non-steroidal anti-inflammatory drugs (NSAIDs) are among the
most commonly prescribed medications that can be obtained over the
counter. Apart from their well-known analgesic, antipyretic and anti-
inflammatory effects, they have also been used in the treatment of
familial adenomatous polyposis (Giardiello et al, 1993). Sulindac, in
particular, has been demonstrated in several epidemiological studies
to significantly reduce the incidence of colonic adenomas and adeno-
carcinomas (Marnett, 1992; Giovannucci et al, 1994). Aspirin use
was inversely associated with fatal cancers of the oesophagus and
stomach as well as colon and rectum, but not generally with fatal
cancers outside the digestive tract (Thun et al, 1993). Record linkage
studies in Finland and Sweden found decreased risk of stomach and
colorectal cancers, but not oesophagus in patients with rheumatoid
arthritis taking high doses of aspirin and other NSAIDs (Isomaki et
al, 1978; Gridley et al, 1993). NSAIDs, such as indomethacin, have
been shown to inhibit the growth of colon cancer cell lines and
induce apoptosis in vitro, which was considered to be an important
mechanism in their antineoplastic activity (Hanif et al, 1996; Shiff et
al, 1996). Furthermore, apoptosis has been implicated to play a vital
role in gastric epithelial cell turnover, ulcerogenesis and even
carcinogenesis (Hall et al, 1994; Spyridon et al, 1994). A study of the
effects of NSAIDs on apoptosis of gastric epithelial cells and its
underlying intracellular events could present novel points for thera-
peutic intervention in gastropathy.
Protein kinase C (PKC), a serine—threonine kinase, is a family of
12 isoenzymes which mediate phosphorylation of numerous protein
substrates and play a central role in signalling pathways regulating
cell differentiation, tumour promotion and apoptosis (Clemens et al,
1992; Lucas and Sanchez-Margalet, 1995; Deacon et al, 1997).
Phorbol esters, such as 12-O-tetradecanoylphorbol 13-acetate
(TPA), activate PKC in vitro in a manner similar to the physiological
activator diacylglycerol (DAG) and have, therefore, been widely
used to study the function of PKC. Both induction and inhibition of
apoptosis have been reported in different cell lines treated with TPA
(Lucas and Sanchez-Margalet, 1995). These contradictory findings
may be because it can activate several PKC isoenzymes. Unlike the
physiological activator DAG, TPA is a stable compound which will
induce a persistent activation of PKC leading to its down-regulation.
The PKC isoenzymes are differentially sensitive to down-regula-
tion. So, the diverse biological effects of phorbol esters are related to
the differential activation or down-regulation of one or more of the
isoenzymes (Deacon et al, 1997).
Oncogenes and tumour-suppressor genes are well documented
to be involved in mediating apoptosis (Liebermann et al, 1995;
Hale et al, 1996). p53 is a transcription factor which stimulates the
synthesis of inhibitors of cyclin-dependent kinases (CDKs), such
as p21waf1/cip1 which binds to CDKs and inhibits their action,
thereby, blocking cell proliferation (Xiong et al, 1993; El Deiry et
al, 1994). When mammalian cells are exposed to ionizing irradia-
tion or other DNA-damaging agents, the cells are arrested at G1
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induced apoptosis and accumulate cells in G2/M. Overexpression of c-myc was inhibited by TPA and p21waf1/cip1 mRNA increased. In
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Hospital, Hong Kongphase until the genomic lesions are fully repaired. If the damage to
DNA is irreparable, p53 triggers apoptosis. Cells without p53 or
with mutant p53 genes lack this checkpoint and cells enter S-phase
without appropriate DNA repair, leading to fixation and propaga-
tion of genetic alteration (Hale et al, 1996). The c-myc proto-onco-
gene plays a role in the control of cell proliferation, differentiation
as well as apoptosis (Askew et al, 1991; Evans et al, 1992).
Deregulated expression of c-myc can induce apoptosis in conjunc-
tion with growth-regulating signals, such as growth factor depriva-
tion, high cell density and chemotherapeutic treatment (Evans et
al, 1992; Lotem and Sachs, 1993). c-myc antisense oligodeoxy-
nucleotides can inhibit the intracellular expression of the targeted
gene specifically because of the exquisite specificity of the
Watson—Crick base-pair interactions that result in the formation of
mRNA—DNA hybrid structure. Antisense techniques have been
widely used in studying the role of c-myc in apoptosis.
In this study, we have tested the effects of aspirin and
indomethacin on a gastric (AGS) cancer cell line and investigated
the roles of both drugs on cell growth and apoptosis. The mecha-
nisms associated with these changes were also studied, including
the PKC signalling pathways and apoptosis-related genes
including p53, p21waf1/cip1 and c-myc.
MATERIALS AND METHODS
Cell culture
AGS, a poorly differentiated gastric adenocarcinoma cell line, was
purchased from American Type Culture Collection (ATCC,
Rockville, MD, USA) and used in the present study. Cells were
passaged into RPMI-1640 medium containing 10% fetal bovine
serum (FBS), 100 U ml—1penicillin, 100 mg ml—1streptomycin (Gibco
BRL, Life Technologies, NY, USA). Cells were cultured in 25 cm2
culture flasks (Corning, New York, NY, USA) as a monolayer in a
95% air/5% carbon dioxide humidified atmosphere at 37°C.
Both indomethacin and aspirin (Sigma, St Louis, MO, USA)
were freshly prepared in absolute ethanol before use. TPA
(CalBiochem, La Jolla, CA, USA) was prepared in DMSO. Stock
preparations of the reagents were stored at —20°C. Vehicle controls
of absolute ethanol and DMSO (less than 0.1%) were included in
the studies. Cells were incubated for 24 h with different concentra-
tions of indomethacin, aspirin, and TPA alone or in combination.
After treatment, adherent cells were removed by trypsinization
and combined with the floating cells in the medium (Hanif et al,
1996). Cells were collected by centrifugation for further analysis.
Antisense and sense oligonucleotides for c-myc were purchased
from Biognostik (Germany). For oligonucleotide experiments,
cells growing in log phase were seeded in 24-well plates at a
density of 1 ´ 105 cells per well. Specified concentrations of
oligonucleotides were added to the cell culture for 14 h, then
indomethacin (400 mM) was added to the culture for a fixed time
period for further analysis.
MTT assay
Antiproliferation effects were measured by a modified MTT assay
(Carmichael et al, 1988). The assay detects living but not dead
cells, and the signal generated is dependent on the degree of acti-
vation of the cells. About 5000 cells per well were plated in 96-
well microtitre plates and incubated overnight in 100 ml of culture
media. Then cells were treated with various concentrations of
indomethacin or aspirin for fixed time intervals. Ten microlitres of
stock MTT (2.5 mg ml—1) was then added to each well, and the cells
were further incubated at 37°C for 4 h. The supernatant was
removed and 100 ml of 0.04 M hydrochloric acid in isopropanol was
added to each well. The absorbance at a wavelength of 595 nm was
measured by a microELISA reader (BioRad, USA). The negative
control well has no cells, but the culture medium only.
Flow cytometry
Cells from both treatment and control groups were collected and
washed with ice-cold phosphate buffered saline (PBS, pH 7.4).
They were fixed in ice-cold 70% ethanol in PBS and stored at
—20°C. Before analysis, the cells were washed and resuspended in
PBS. One hundred microlitres of RNAase I (1 mg ml—1) and 100 ml
of propidium iodide (PI, 400 mg ml—1, Sigma) were added and
incubated at 37°C for 30 min. The analysis of samples was
performed by a flow cytometry (Coulter Epics XL, UK). The cell
cycle phase distribution was calculated from the resultant DNA
histogram using Multicycle AV software (Phoenix Flow System,
San Diego, CA, USA) and expressed as a percentage of cells in
G0/G1, S- and G2/M phases. The apoptotic cells can be observed on
a DNA histogram as a subdiploid or ￿pre-G1￿ peak (Darzynkiewicz
et al, 1992).
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Figure 1 Dose–response of aspirin and indomethacin on growth of AGS
cells. Cells were treated with various concentration of aspirin (A) or
indomethacin (B) for different time periods. The cell proliferation was
determined by MTT assay. The values are expressed as means ± s.d. (n > 3)DNA fragmentation analysis
DNA fragmentation was analysed as described previously (Grant
et al, 1992) with some modification. Briefly, after treatment with
various agents as described above, cells were harvested and
washed twice in ice-cold PBS. The final pellet was lysed in 10 mM
tris-HCl (pH 7.4) buffer containing 25 mM EDTA, 0.5% SDS and
0.1 mg ml—1 proteinase K (Sigma) and incubated at 50°C for 12—
18 h. DNA was extracted with an equal volume of phenol/chloro-
form/isoamyl alcohol (25:24:1) and precipitated with two volumes
of ice-cold absolute ethanol and 1/10 volume 3 M sodium acetate.
DNA was collected, washed once with 70% ethanol, and dissolved
in TE buffer (10 mM Tris and 1 mM EDTA, pH 8.0). DNA samples
were incubated with 10 mg ml—1 RNAase I (Sigma) for 1 h at 37°C.
Equal amounts (10 mg per well) of DNA was electrophoresed
in 1.8% agarose gels impregnated with ethidium bromide
(0.1 mg ml—1) for 2 h at 60 V. DNA marker (50—1000 bp, FMC,
Rockland, ME, USA) was run at the same time. DNA fragments
in the form of laddering pattern were visualized by ultraviolet
transillumination.
Acridine orange staining
Single-cell suspensions were fixed in 1% formalin/PBS and
stained with acridine orange (AO, 10 mg ml—1, Sigma). A drop
of the stained cell suspension was placed on a microscope slide.
Cells were visualized under UV fluorescence microscope with
blue—green filter, as described previously (Elder et al, 1996).
Apoptotic cells were defined as cells showing cytoplasmic and
nuclear shrinkage and chromatin condensation or fragmentation
morphologically. At least 300 cells were counted and the
percentage of apoptotic cells was determined.
RNA preparation and Northern blot analysis
Total cellular RNA was isolated following the methods as described
previously (Rhoads, 1975) after some modification. Briefly, cells
were washed with ice-cold PBS, lysed with 4 M lithium chloride/8 M
urea/6 mM EDTA and then precipitated overnight at 4°C. After
centrifugation for 15 min at 13 000 r.p.m. at 4°C, the RNA pellet
was dissolved in DEPC-treated water, extracted with phenol/chloro-
form/isoamyl alcohol (25:24:1), and then precipitated with ethanol
and sodium acetate. Northern blot analysis was performed according
to the method previously described (Ausubel et al, 1995). Equal
amounts (20 mg) of total RNA per lane were electrophoresed on
1.0% denaturing formaldehyde agarose gel and transferred onto
nylon membranes (Amersham, UK). The cDNA probes of p53, c-
myc (Oncogene Research Products, Cambridge, MA, USA) and
waf1 probe from pSXV-WAF1 (ATCC) excised by EcoRI and XhoI
(New England Biolabs, Beverly, MA, USA) were radiolabelled with
[a-32P]dCTP (Amersham) by the Megaprime random prime
labelling system (Amersham). After hybridization with a different
probe overnight at 42°C, the membrane was washed with 2.0 ´
sodium chloride, sodium phosphate EDTA buffer (SSPE)/0.1%
SDS, 1.0 ´SSPE/0.1% SDS and 0.2 ´SSPE/0.1% SDS at 42°C, and
exposed to radiographic film (Kodak, Rochester, NY, USA)
at —70°C. The membrane was reprobed for use in another
hybridization in which a glyceraldehyde-3-phosphate dehydro-
genase (GAPDH) mRNA served as an internal control. GAPDH
oligonucleotide probe (Oncogene Research Products) was radio-
labelled with [g-32P] ATP by 5¢-end labelling kit (Amersham).
Western blot analysis
After the drug treatment, the cells were extracted with lysis buffer
containing 1% Triton ´ 100, 50 mM sodium chloride, 50 mM sodium
fluoride, 20 mM Tris, pH 7.4, 1 mM EDTA, 1 mM EGTA, 1 mM
sodium vanadate, 0.2 mM PMSF and 0.5% NP-40. The protein
concentration was determined by using Bicinchoninic acid assay
(BCA) (Smith et al, 1985) with bovine serum albumin (Sigma) as
standard. Western blotting was carried out as described previously
(Li et al, 1996). In brief, equal amount of cell lysates (60 mg) were
solubilized in sample buffer by boiling for 5 min and subjected to
10% sodium dodecyl sulphate polyacrylamide gel electrophoresis
(SDS-PAGE) followed by electrotransfer onto a nitrocellulose
membrane (Sigma). The membrane was incubated first with an
appropriate primary antibody and then with peroxidase-conjugated
anti-mouse IgG antibody in the second reaction. The membranes
were washed and developed by chemiluminescence (ECL) Western
blot detection system (Transduction Laboratories, Lexington, KY,
USA) and exposed to film. Mouse monoclonal antibodies p53 (Ab-
6), p21waf1/cip1 (Ab-1), c-Myc (Ab-1) and peroxidase-conjugated anti-
mouse IgG were purchased from Oncogene Research Products.
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Figure 2 Cell cycle phase distribution and apoptosis of AGS cells treated
with aspirin and indomethacin. Cells were treated with various concentrations
of aspirin (A) or indomethacin (B) for 24 h and harvested. The cell cycle
phase distribution and apoptosis was determined by FACS analysis. The
values are expressed as means ± s.d. (n > 3)
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The data shown were mean values of at least three different exper-
iments and expressed as means ± s.d. Student￿s t-test was used to
compare the results. A P-value of less than 0.05 is considered
statistically significant.
RESULTS
Effects of aspirin and indomethacin on cell growth
To evaluate the effects of aspirin and indomethacin on the growth
of gastric cancer cells in vitro, cells were seeded in 96-well culture
plates at a density of 5000 cells per well. Various concentrations of
aspirin (0.1—10 mM) and indomethacin (50—800 mM) were added in
the culture medium for 1, 2 or 3 days. Cell growth was determined
by MTT assay. As Figure 1 shows, both indomethacin and aspirin
could inhibit gastric cancer cell growth in a dose- and time-
dependent manner. Indomethacin showed a more potent effect on
reducing AGS cell growth compared with aspirin.
Effect of aspirin and indomethacin on the cell cycle
phase distribution
To investigate the antiproliferation mechanisms of aspirin and
indomethacin, we studied the effect of these compounds on cell cycle
phase distribution of gastric adenocarcinoma cells using FACS
analysis. The results showed that after the indicated treatments for
24 h, neither aspirin nor indomethacin interfered with cell cycle phase
distribution of AGS cells when compared with the control (Figure 2).
Apoptosis of gastric cancer cells induced by aspirin
and indomethacin
Apoptosis of gastric cancer cells after treatment was evaluated by
three different methods as described above: (1) measurement of
DNA content of cells by PI staining and FACS analysis to detect
the pre-G1 peak; (2) agarose gel electrophoresis of genomic DNA
to detect DNA fragmentation; (3) AO staining to detect the typical
morphological changes under fluorescence microscopy. The FACS
analysis showed that both aspirin and indomethacin could induce
apoptosis in AGS cells, with a typical subdiploid peak on the
histogram (Figure 3A). Apoptosis induction followed a dose-
dependent and non-linear manner (Figure 2). Compared with
indomethacin, aspirin was less potent in inducing apoptosis of
AGS cells. It failed to induce apoptosis at †0.1 mM. DNA frag-
mentation in AGS cells treated with aspirin (1 mM, 10 mM) and
indomethacin (100—800 mM) was shown as a ladder pattern on
agarose gel (Figure 4). The AO staining showed that both aspirin
and indomethacin could induce apoptosis in AGS cells morpho-
logically, which was characterized by cytoplasmic and nuclear
shrinkage, chromatin condensation and fragmentation (Figure 5).
Effect of 12-O-betradecanoyl phorbol 13-acetate (TPA)
on indomethacin-induced apoptosis and cell cycle
To study whether the PKC pathway is mediated in apoptosis
induction by indomethacin, we investigated the effect of the PKC
activator TPA, a pan-activator of PKC isoenzymes affecting all but
the atypical class of PKCs (z,  l,  m) (Jarvis et al, 1994), on
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Figure 3 The results of FACS analysis of AGS cells treated with aspirin and indomethacin with or without TPA. Cells were treated with aspirin, indomethacin
and TPA alone or in combination for 24 h and their DNA content was determined by FACS, as described in Materials and methods. (A) DNA histogram. (a)
control; (b) 1 mM aspirin; (c) 400 mM indomethacin; (d) 400 mM indomethacin + 100 nM TPA; (B) TPA on apoptosis and cell kinetics of indomethacin-treated AGS
cells. The values are expressed as means ± s.d. (n > 3)indomethacin-induced apoptosis of AGS cells. As a result, the
proportion of cells in the G0/G1 phase was significantly decreased
and that in G2/M phase was increased after chronic treatment with
TPA alone at 100 nM for 24 h (Figure 3B). Indomethacin-induced
apoptosis was inhibited by co-incubation with 100 nM TPA,
decreasing from 50.2±10% to 16.4±6.7%. In addition, cells at
G0/G1 phase were reduced from 74.8±3.6% to 60.6±4.7% (P<0.05)
and those at G2/M phase was increased from 11.5±3.6% to
33.6±6.6% (P<0.01) (Figure 3B).
Effects of indomethacin on p53, p21waf1/cip1 and c-myc
mRNA level
The mRNA level of p53, p21waf1/cip1 and c-myc was determined by
Northern blotting in indomethacin-treated AGS cells. Cells
exposed to 400 mM of indomethacin resulted in a progressive
increase in c-myc mRNA levels noted as early as 2 h and reached a
maximum at 8 h, whereas p53 and p21waf1/cip1 mRNA remained
unchanged over time. Equal amounts of RNA were loaded in each
lane, as determined by hybridization with the internal control
GAPDH probe (Figure 6A).
Effects of indomethacin on p53, p21waf1/cip1 and c-myc
protein level
The protein levels of p53, p21waf1/cip1 and c-myc were determined
by Western blotting in indomethacin-treated AGS cells. Cells
treated with 400 mM of indomethacin resulted in a marked increase
in c-myc protein level noted as early as 4 h and reached a
maximum at 8 h, whereas p53 and p21waf1/cip1 protein levels
remained unchanged (Figure 6B).
Effect of TPA on p53, p21waf1/cip1 and c-myc mRNA level
in indomethacin-treated AGS cells
Figure 7 shows that 100 nM TPA greatly inhibited the overexpres-
sion of c-myc mRNA induced by indomethacin (400 mM) at 8 h.
However, p21waf1/cip1 mRNA was increased at 8 h, whereas p53
mRNA remained unchanged. Equal amounts of RNA were loaded
in each lane, as determined by hybridization with the internal
control GAPDH probe.
Down-regulation of c-myc with its antisense
oligonucleotides on indomethacin-induced apoptosis
The role of c-myc proto-oncogene in indomethacin-induced apop-
tosis was confirmed using various concentrations of antisense
oligonucleotides. Figure 8 shows that 2 mM c-myc antisense
oligonucleotide could inhibit the indomethacin-induced increase
in c-myc protein at 8 h, whereas sense oligonucleotide, as a
random control, showed no effect on the c-myc overexpression.
c-myc antisense oligonucleotide could inhibit the indomethacin-
induced apoptosis. At 400 mM of indomethacin, the percentage of
apoptotic cells decreased from 50.3±3.2% to 24.7±2.1% by the
addition of 2 mM of antisense oligonucleotide. The same concen-
tration of c-myc sense oligonucleotides showed no effect on apop-
tosis induced by indomethacin.
DISCUSSION
It has been demonstrated for the first time in this study that both
aspirin and indomethacin can inhibit the growth of AGS gastric
NSAID-induced apoptosis in gastric cancer cells 397
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Figure 4 Induction of DNA fragmentation by indomethacin and aspirin. AGS
cells were exposed to the agents indicated for 24 h and the formation of
oligonucleosomal fragments was determined by agarose gel electrophoresis
as described in the text. M, DNA marker; lanes 1–3, aspirin 10, 1, 0.1 mM;
lane 4, control. Lanes 5–9, indomethacin 800, 400, 200, 100, 50 mM; lane 10,
control
Figure 5 Fluorescence photograph of AGS cells treated with indomethacin.
Cells were treated with 400 mM indomethacin for 24 h. The cells were
stained with acridine orange and examined under fluorescence microscopy.
(A) control; (B) treated with indomethacin
A
Bcancer cells in a concentration- and time-dependent fashion.
Moreover, aspirin and indomethacin induced apoptosis in the AGS
cancer cells. Indomethacin showed more potent growth inhibition
on AGS cells compared with aspirin. Similarly, apoptosis was
induced by indomethacin at a lower concentration than aspirin.
These findings are consistent with those reported in colon cancer
and other cell lines (Lu et al, 1995; Shiff et al, 1996). Apoptosis is
often accompanied by growth arrest. Cell cycle checkpoints may
acts as a toggle switch between proliferation and death by sensing
deregulation of the cell cycle (King and Cidlowski, 1995). In
colon cancer cells, the apoptotic effect of NSAIDs correlated with
the arrest of cells at G0/G1 phase (Hanif et al, 1996; Shiff et al,
1996). We failed to demonstrate any effect of aspirin or
indomethacin on the AGS cell cycle phase distribution by using
the FACS analysis. Thus, apoptosis may be the chief mechanism
responsible for the inhibition of cell growth in NSAID-treated
AGS cancer cells.
Although the role of NSAIDs in the induction of apoptosis of
colon cancer cells are reported (Hanif et al, 1996; Shiff et al,
1996), the intracellular molecular events involved are still by far
unknown. One potential molecular target for NSAIDs is cyclo-
oxygenases (COXs), a key enzyme in prostaglandin biosynthesis.
Interestingly, sulindac sulphone (an active metabolite of sulindac),
which induced apoptosis in colon carcinoma cells HT29, is inde-
pendent of inhibiting prostaglandin biosynthesis (Hanif et al,
1996). In our present study, we found that prolonged incubation
with a PKC activator significantly reduced the apoptotic effect of
indomethacin in the AGS cells. Thus, the protein kinase C
pathway may be associated with NSAID-induced apoptosis in
gastric cancer cells.
A high prevalence of p53 mutation has been detected in gastric
cancer (Uchino et al, 1993; Triantafillou et al, 1996). In
indomethacin-treated AGS cells, we did not observe any change in
p53 mRNA and protein expression. The p53 target gene p21waf1/cip1
also showed no change after the treatment with indomethacin,
which might explain the unaltered cell cycle phase distribution. In
HT-29 colon cancer cells, however, both sulindac and sulindac
sulphide increased the level of p21waf1/cip1 expression but reduced
the level of mutant p53 (Goldberg et al, 1996). The differential
regulation of tumour-suppressor genes in relation to apoptosis in
cells from different gastrointestinal sites needs to be explored.
c-myc mRNA is overexpressed in most cases of primary gastric
carcinoma. Metastatic lesions also have high levels of expression,
which suggests that overexpression of c-myc may play a role in
gastric carcinogenesis and tumour metastasis (Onoda et al, 1996).
Our results showed that c-myc gene expression was up-regulated
at both mRNA and protein level, preceding the onset of apoptosis
after treatment with indomethacin. Down-regulation of the c-myc
overexpression by antisense oligonucleotides inhibited the
indomethacin-induced apoptosis of AGS cells, which suggested
that c-myc was involved in indomethacin-induced apoptosis.
Further evidence came from the down-regulation of c-myc after
TPA co-treatment, which also reversed indomethacin-induced
apoptosis. c-myc-mediated apoptosis in epithelial cells could be
p53 dependent or independent (Sakamuro et al, 1995). AGS cells
express wild-type p53 (Matozaki et al, 1992). After treatment with
indomethacin, p53 mRNA remained unchanged, although the
c-myc mRNA was markedly increased. It has been shown that
normal levels of wild-type p53 in the fibroblast system are suffi-
cient to confer susceptibility to c-myc-mediated apoptosis (Wagner
398 GH Zhu et al
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Figure 6 The expression of p53, p21waf1/cip1 and c-myc mRNA and protein in
AGS cells treated by indomethacin. The AGS cells were exposed to 400 mM
indomethacin for different intervals (0, 2, 4, 8, 12, 16, 24 h). The mRNA and
protein level of p53, p21waf1/cip1 and c-myc were determined by Northern and
Western blot. The results are the representative of three different
experiments. (A) Northern blot result. GAPDH was used as an internal
control. (B) Immunoblot analysis
Figure 7 The effect of TPA on the expression of p53, p21waf1/cip1 and c-myc
mRNA in indomethacin-induced AGS. The AGS cells were treated with
indomethacin (400 mM) alone or in combination with 100 nM TPA for 8 h. The
mRNA level of p53, p21waf1/cip1 and c-myc were determined by Northern blot.
Lane 1, control; lane 2, 400 mM indomethacin; lane 3, 400 mM indomethacin +
100 nM TPA. The house-keeping gene GAPDH was used as an internal
control (the representative of three different experiments)
Figure 8 Effect of oligonucleotides on c-myc protein expression. AGS cells
were cultured with antisense or sense oligonucleotides (2 mM) for 18 h before
incubation with 400 mM indomethacin for another 8 h, after which cell lysates
was collected and c-myc protein was determined by Western blotting. Lane
1, control; lane 2, 400 mM indomethacin; lane 3, 400 mM indomethacin+2 mM
sense oligos; lane 4, 400 mM indomethacin+2 mM antisense. This experiment
was repeated three times and one representative result is shown in this
figure
p53
p21waf1/cip1
c-myc
GAPDH
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1234et al, 1994). Further study is needed to better define the interaction
of the two genes in apoptosis.
We found that TPA could reduce the proportion of AGS cells at
G0/G1 phase and increase the cells at G2/M phase in the presence or
absence of indomethacin. Usually, cells progress to late G1 phase
before apoptosis takes place. Cell cycle arrest before this stage
delays or blocks apoptosis, whereas arrest after this promotes
apoptosis (Meikrantz et al, 1994). It may be possible that TPA
inhibits indomethacin-induced apoptosis via modulation of cell
cycle kinetics. In cells treated with PKC activator in the presence
of indomethacin, p21waf1/cip1 protein expression was increased, but
not accompanied by an increase in p53 protein expression.
Therefore, activation/down-regulation of protein kinase C could
lead to overexpression of p21waf1/cip1 in gastric cancer cells that is
independent of p53. This finding agrees with previous studies
showing that p21waf1/cip1 can be induced through p53-independent
mechanisms by TPA in other cell types (Michieli et al, 1994).
p21waf1/cip1 has been commonly associated with the G1 check point.
However, it has been shown to accumulate cells in G2/M phase in
some cell types treated with TPA (Tchou et al, 1996). In our
present study, overexpression of p21waf1/cip1 may be associated with
the accumulation of cells at G2/M phase after TPA treatment.
We conclude from our experiments that both aspirin and
indomethacin induce apoptosis in AGS gastric cancer cells, which
may account for their growth inhibitory effects. The modulation of
PKC activity and down-regulation of c-myc may block these
effects. We believe that further understanding of the NSAID-
induced apoptosis in gastric cancer can lead to some insight into
the carcinogenesis and chemoprevention of the second most
common cancer in the world.
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